Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).

Sedlis SP, Jurkovitz CT, Hartigan PM, Kolm P, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, Boden WE, Weintraub WS; COURAGE Study Investigators.

Am J Cardiol. 2013 Dec 1;112(11):1703-8. doi: 10.1016/j.amjcard.2013.07.034. Epub 2013 Sep 3.

PMID:
24011740
[PubMed - indexed for MEDLINE]
2.

Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.

Sedlis SP, Jurkovitz CT, Hartigan PM, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, O'Rourke RA, Boden WE, Weintraub WS; COURAGE Study Investigators.

Am J Cardiol. 2009 Dec 15;104(12):1647-53. doi: 10.1016/j.amjcard.2009.07.043.

PMID:
19962469
[PubMed - indexed for MEDLINE]
3.

Re: One year perspective on COURAGE.

Sedlis SP, Boden WE, Weintraub WS, Maron DS, O'Rourke RA, Berman DS, Mancini GB; COURAGE study Investigators.

Catheter Cardiovasc Interv. 2009 Feb 15;73(3):428. doi: 10.1002/ccd.21848. No abstract available.

PMID:
19133682
[PubMed - indexed for MEDLINE]
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk